Bruker Corporation BRKR | NASDAQ

$41.80 -$0.38 | -0.90%

After Hours
$42.25 $0.45 | 1.08%

Next Earnings: Aug 04, 2025

Company Overview:

Market Cap: $6.33B
PE Ratio: 80.38
52-Week Range: $34.10 - $72.94
Dividend Yield (FWD): 0.48% ($0.20)

10 Year BRKR Performance Metrics:

Total Return (with DRIP): 112.9% (7.85% CAGR)
Total Return (no DRIP): 112.9% (7.85% CAGR)
Share Price: 104.8% (7.43% CAGR)
Dividend Increase: 25.0% (2.44% CAGR)
BRKR 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

BRKR Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
BRKR Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 4.56%10Y: N/A
Share Price
BRKR Price CAGR:1Y: -34.89%2Y: -24.40%5Y: 1.95%10Y: 7.18%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

BRKR Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - BRKR
7-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - BRKR
7-Day FREE Trial Get Full Access Now!

BRKR Earnings, Revenue, Cash & Debt, Shares Outstaning:

BRKR - Revenue
7-Day FREE Trial Get Full Access Now!
BRKR Revenue CAGR:1Y: 11.04%2Y: 8.14%5Y: 13.58%10Y: 8.53%
BRKR - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
BRKR EPS CAGR:1Y: -68.57%2Y: -54.01%5Y: 9.46%10Y: 10.65%
BRKR - Net Income
7-Day FREE Trial Get Full Access Now!
BRKR Net Income CAGR:1Y: -65.82%2Y: -52.31%5Y: 10.63%10Y: 10.35%
BRKR - EBITDA
7-Day FREE Trial Get Full Access Now!
BRKR EBITDA CAGR:1Y: -22.35%2Y: -23.93%5Y: 16.32%10Y: 7.78%
BRKR - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
BRKR Free Cash Flow CAGR:1Y: 9,650.00%2Y: -21.01%5Y: 54.02%10Y: 6.24%
BRKR - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
BRKR Free Cash Flow / Share CAGR:1Y: 9,238.46%2Y: -22.27%5Y: 54.54%10Y: 7.35%
BRKR - Operating Income
7-Day FREE Trial Get Full Access Now!
BRKR Operating Income CAGR:1Y: -59.54%2Y: -49.09%5Y: 14.16%10Y: 7.66%
BRKR - Gross Profit
7-Day FREE Trial Get Full Access Now!
BRKR Gross Profit CAGR:1Y: 9.73%2Y: 4.29%5Y: 15.26%10Y: 9.34%
BRKR - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
BRKR Shares Outstanding CAGR:1Y: 4.11%2Y: 1.45%5Y: -0.45%10Y: -1.10%
BRKR - Share Buybacks
7-Day FREE Trial Get Full Access Now!
BRKR Share Buybacks CAGR:1Y: 0.00%2Y: -33.18%5Y: -44.95%10Y: 0.00%
BRKR - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
BRKR Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
BRKR - Expenses
7-Day FREE Trial Get Full Access Now!
BRKR Expenses CAGR:1Y: 21.50%2Y: 1.98%5Y: -3.14%10Y: 16.39%
BRKR - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
BRKR - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
BRKR - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
BRKR - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
BRKR - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
BRKR - Cash & Debt
7-Day FREE Trial Get Full Access Now!
BRKR - Dividends
7-Day FREE Trial Get Full Access Now!
BRKR Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 4.56%10Y: N/A
BRKR - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
BRKR Revenue CAGR:1Y: 11.04%2Y: 8.14%5Y: 13.58%10Y: 8.53%
BRKR - Revenue by Region
7-Day FREE Trial Get Full Access Now!
BRKR Revenue CAGR:1Y: 11.04%2Y: 8.14%5Y: 13.58%10Y: 8.53%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

BRKR - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
BRKR Actual Revenue CAGR:1Y: 11.04%2Y: 8.14%5Y: 13.58%10Y: 8.53%
BRKR - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
BRKR Actual EPS CAGR:1Y: -68.57%2Y: -54.01%5Y: 9.46%10Y: 10.65%
BRKR - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
BRKR Actual Net Income CAGR:1Y: -65.82%2Y: -52.31%5Y: 10.63%10Y: 10.35%
BRKR - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
BRKR Actual EBITDA CAGR:1Y: -22.35%2Y: -23.93%5Y: 16.32%10Y: 7.78%

Ratios, Profit Margins & Return on Capital:

BRKR - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
BRKR Net Profit Margin CAGR:1Y: -69.22%2Y: -55.90%5Y: -2.64%10Y: 1.66%
BRKR - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
BRKR Gross Profit Margin CAGR:1Y: -1.19%2Y: -3.57%5Y: 1.48%10Y: 0.74%
BRKR - Price to Earnings
7-Day FREE Trial Get Full Access Now!
BRKR - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
BRKR - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
BRKR - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

BRKR Dividends Info:

Annual Dividend: $0.2
Forward Yield: 0.48%
Ex-Dividend Date: 2025-06-16
Lifetime Dividends / Share: $1.71

BRKR Dividend History: Dates, Payments & Yield list

Below is a schedule of all BRKR dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
06/16/202506/27/2025$0.0500.51%0.48%$41.80
03/17/202503/28/2025$0.0500.43%0.48%$42.08
12/02/202412/16/2024$0.0500.34%0.35%$57.18
08/30/202409/16/2024$0.0500.3%0.31%$65.28
06/03/202406/17/2024$0.0500.31%0.31%$64.85
05/31/202406/17/2024$0.0500.31%0.31%$64.85
02/29/202403/15/2024$0.0500.23%0.22%$92.10
11/30/202312/15/2023$0.0500.31%0.27%$73.36
08/31/202309/15/2023$0.0500.3%0.3%$66.43
05/31/202306/16/2023$0.0500.29%0.26%$75.48
02/28/202303/17/2023$0.0500.29%0.28%$72.18
11/30/202212/16/2022$0.0500.3%0.31%$64.41
08/31/202209/16/2022$0.0500.34%0.38%$52.88
05/31/202206/17/2022$0.0500.29%0.34%$59.28
02/28/202203/18/2022$0.0500.24%0.29%$68.64
11/30/202112/17/2021$0.0400.2%0.2%$78.55
08/31/202109/17/2021$0.0400.18%0.19%$83.35
05/28/202106/18/2021$0.0400.23%0.22%$72.29
03/04/202103/19/2021$0.0400.27%0.26%$60.69
11/30/202012/18/2020$0.0400.32%0.29%$55.48
08/31/202009/18/2020$0.0400.38%0.41%$38.63
05/29/202006/19/2020$0.0400.37%0.39%$41.09
03/06/202003/20/2020$0.0400.36%0.47%$34.37
11/29/201912/20/2019$0.0400.31%0.31%$51.61
08/30/201909/20/2019$0.0400.37%0.37%$43.54
05/31/201906/21/2019$0.0400.38%0.33%$48.76
03/04/201903/22/2019$0.0400.41%0.42%$38.10
11/30/201812/21/2018$0.0400.48%0.6%$26.50
08/31/201809/21/2018$0.0400.45%0.49%$32.87
06/01/201806/22/2018$0.0400.52%0.53%$30.01
03/05/201803/23/2018$0.0400.54%0.55%$29.12
12/01/201712/22/2017$0.0400.46%0.47%$34.08
08/31/201709/22/2017$0.0400.55%0.54%$29.36
06/01/201706/23/2017$0.0400.58%0.53%$29.98
03/06/201703/24/2017$0.0400.67%0.69%$23.19
12/01/201612/23/2016$0.0400.71%0.74%$21.53
09/01/201609/23/2016$0.0400.53%0.72%$22.37
06/02/201606/24/2016$0.0400.3%0.7%$22.90
03/02/201603/24/2016$0.0400.14%0.58%$27.43

Projected Future Returns & Dividends for BRKR

Based on past 10-year performance, here are BRKR growth metrics:

Share price CAGR of +7.18%
Dividend CAGR of +2.44%

Using BRKR CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

BRKR (DRIP)BRKR - No DRIP
Current Price$41.80$41.80
Start Shares239.23239.23
Start Value$10,000$10,000
  
After 10 years:
Final Share Count248.83239.23
Dividends Payment$0.06$0.06
Annual Dividends$63$61
Yield on cost0.63%0.61%
Share Price$78.04$78.04
Total Dividends$546$535
Final Value$19,418$19,203

Estimated Future Value + Dividends - BRKR

NOTE: Above numbers are our estimate based on BRKR's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Bruker Corporation (BRKR) had its IPO on 2000-08-04, and is trader on NASDAQ stock exchange.

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

BRKR website: https://www.bruker.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial